You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The analysis further discovered that endemic cholera strains in Argentina were more diverse, a finding that could inform outbreak control efforts.
In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.
In Nature this week: genome-wide association study of 42 diseases among Japanese population, transfer RNA modifications, and more.
In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.
In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.
In PLOS this week: improved imputation, evolution of Vibrio cholerae isolates from recent outbreak, and more.
In PNAS this week: emerging songbird pathogen Mycoplasma gallisepticum, CRISPR-Cas9-based knockdown finds role for lipoprotein transport in viability, and more.
In PLOS this week: single protein identification method, Vibrio cholerae sequences from spotted filter paper, and more.
Researchers found a potential alternative toxin, as well as antibiotic resistance genes, in a newly-sequenced Vibrio cholerae strain from a British WWI soldier.
In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.
According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.
CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.
Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.
In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.